- June 17, 2016 | BY
The growing pace of outsourced drug discovery, using a gut microbe to alter autism-like symptoms in mice, and testing a controversial theory about how tumors spread.
- June 14, 2016 | BY
Using optogenetics, two researchers challenge our notions of movement and offer new and more reliable ways to model movement disorders in animals
- June 10, 2016 | BY
How a toxic liver drug may boost gene therapy, committee seeks clarity on gene drive, the link between touch and autism, and a long-awaited overhaul of US chemical laws. This week in Abstract Science.
- June 8, 2016 | BY
Can colistin help overcome some of the challenges in treating E. coli with antibiotics?
- June 7, 2016 | BY
Two-year effort identifies several compounds suitable for proof-of-concept studies.
- June 3, 2016 | BY
The search for other vectors spreading Zika, discouraging statistics about the use of osteoporosis drugs, and a virologist prepares for space travel.
- June 2, 2016 | BY
If there is one thing we’re learning from decades of studying tumors, it’s that they are highly diverse, not just from cancer type to cancer type, but also from patient to patient.
- May 27, 2016 | BY
New insights into Alzheimer’s classic villain, more on the irreproducibility program, and giving CRISPR greater utility in brain research. This week in Abstract Science.
- May 26, 2016 | BY
How optical imaging strategies are opening a window on tumors.
- May 20, 2016 | BY
Changes in store for US chemical safety laws, Zika politics and building antibiotics from scratch.